What is the material used in the implantable contact lens known as IPCL?

It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.

When did IPCL obtain regulatory approval from the Ministry of Health, Labour and Welfare in Japan?

It obtained regulatory approval from the Ministry of Health, Labour and Welfare in Japan in April 2025.

How does the IPCL treatment correct vision problems such as myopia and astigmatism?

It corrects these vision problems by inserting a small lens made of acrylic polymer material into the eye.

Why is the IPCL treatment considered a highly reversible procedure unlike LASIK?

It does not involve shaving the cornea, making it highly reversible as the lens can be removed in the future.

What percentage of the survey subjects were interested in implantable contact lenses as a treatment?

About 70 percent, specifically 71.9 percent, of the survey subjects expressed interest in it as a treatment method.

AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 50/100

AI Summary (NQ-processed)

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the material used in the implantable contact lens known as IPCL?: A: It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.
Q: When did IPCL obtain regulatory approval from the Ministry of Health, Labour and Welfare in Japan?: A: It obtained regulatory approval from the Ministry of Health, Labour and Welfare in Japan in April 2025.
Q: How does the IPCL treatment correct vision problems such as myopia and astigmatism?: A: It corrects these vision problems by inserting a small lens made of acrylic polymer material into the eye.
Q: Why is the IPCL treatment considered a highly reversible procedure unlike LASIK?: A: It does not involve shaving the cornea, making it highly reversible as the lens can be removed in the future.
Q: What percentage of the survey subjects were interested in implantable contact lenses as a treatment?: A: About 70 percent, specifically 71.9 percent, of the survey subjects expressed interest in it as a treatment method.